GERN vs. RMD
GERN (Geron Corporation) and RMD (ResMed Inc.) are both stocks. Both are in the Healthcare sector — GERN in Biotechnology, RMD in Medical Instruments & Supplies. Over the past 10 years, GERN returned -7.19%/yr vs 13.03%/yr for RMD. Their 0.23 correlation means their historical movements had little consistent relationship.
Performance
GERN vs. RMD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GERN achieves a -2.27% return, which is significantly higher than RMD's -11.95% return. Over the past 10 years, GERN has underperformed RMD with an annualized return of -7.19%, while RMD has yielded a comparatively higher 13.03% annualized return.
GERN
- 1D
- -3.73%
- 1M
- -5.15%
- 6M
- -5.84%
- YTD
- -2.27%
- 1Y
- 10.26%
- 3Y*
- -26.20%
- 5Y*
- 1.12%
- 10Y*
- -7.19%
- ALL TIME*
- -5.90%
RMD
- 1D
- 1.16%
- 1M
- 0.64%
- 6M
- -17.89%
- YTD
- -11.95%
- 1Y
- -23.69%
- 3Y*
- -1.21%
- 5Y*
- -4.10%
- 10Y*
- 13.03%
- ALL TIME*
- 20.57%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $11.36M | $12.76M | $17.04M | |
RMD ResMed Inc. | $221.77M | $287.46M | $300.95M |
GERN vs. RMD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GERN Geron Corporation | -2.27% | -62.71% | 67.77% | -12.81% | 98.36% | -23.27% | 16.91% | 36.00% | -44.44% | -13.04% |
RMD ResMed Inc. | -11.95% | 6.26% | 34.18% | -16.55% | -19.47% | 23.41% | 38.33% | 37.85% | 36.38% | 39.06% |
Correlation
The correlation between GERN and RMD is 0.18, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.18 |
Correlation (3Y) Balances recent behavior with more history. | 0.19 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.23 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.23 |
Correlation (All Time) Calculated using the full available price history since Jul 31, 1996 | 0.23 |
Fundamentals
GERN:
$827.56M
RMD:
$30.60B
GERN:
-$0.10
RMD:
$15.50
GERN:
4.39
RMD:
3.73
GERN:
$196.12M
RMD:
$5.54B
GERN:
$119.67M
RMD:
$3.42B
GERN:
-$40.62M
RMD:
$2.10B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GERN vs. RMD — Risk / Return Rank
GERN
RMD
GERN vs. RMD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Geron Corporation (GERN) and ResMed Inc. (RMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GERN | RMD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.99 | ||
| Sortino ratioReturn per unit of downside risk | +1.76 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 0.88 | +0.20 |
| Calmar ratioReturn relative to maximum drawdown | 0.28 | -0.58 | +0.86 |
| Martin ratioReturn relative to average drawdown | 0.61 | -1.08 | +1.69 |
Loading charts...
Drawdowns
GERN vs. RMD - Drawdown Comparison
The maximum GERN drawdown since its inception was -98.73%, which is greater than RMD's maximum drawdown of -61.61%. Use the drawdown chart below to compare losses from any high point for GERN and RMD.
Loading charts...
Drawdown Indicators
| GERN | RMD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.73% | -61.61% | -37.12% |
Max Drawdown (1Y)Largest decline over 1 year | -43.59% | -37.28% | -6.31% |
Max Drawdown (3Y)Largest decline over 3 years | -78.98% | -37.28% | -41.70% |
Max Drawdown (5Y)Largest decline over 5 years | -78.98% | -53.99% | -24.99% |
Max Drawdown (10Y)Largest decline over 10 years | -86.09% | -53.99% | -32.10% |
Current DrawdownCurrent decline from peak | -98.15% | -27.62% | -70.53% |
Average DrawdownAverage peak-to-trough decline | -86.21% | -16.06% | -70.15% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.06% | 20.03% | +0.03% |
Volatility
GERN vs. RMD - Volatility Comparison
Geron Corporation (GERN) has a higher volatility of 16.52% compared to ResMed Inc. (RMD) at 12.95%. This indicates that GERN's price experiences larger fluctuations and is considered to be riskier than RMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GERN | RMD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.52% | 12.95% | +3.57% |
Volatility (6M)Calculated over the trailing 6-month period | 46.49% | 23.18% | +23.31% |
Volatility (1Y)Calculated over the trailing 1-year period | 61.70% | 27.51% | +34.19% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 81.29% | 31.52% | +49.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 78.11% | 31.69% | +46.42% |
Dividends
GERN vs. RMD - Dividend Comparison
GERN has not paid dividends to shareholders, while RMD's dividend yield for the trailing twelve months is around 1.14%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GERN Geron Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
RMD ResMed Inc. | 1.14% | 0.94% | 0.88% | 1.07% | 0.83% | 0.62% | 0.73% | 0.98% | 1.26% | 1.61% | 2.03% | 2.16% |
Financials
GERN vs. RMD - Financials Comparison
This section allows you to compare key financial metrics between Geron Corporation and ResMed Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GERN vs. RMD - Profitability Comparison
GERN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Geron Corporation reported a gross profit of 0.00 and revenue of 51.84M. Therefore, the gross margin over that period was 0.0%.
RMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, ResMed Inc. reported a gross profit of 890.98M and revenue of 1.43B. Therefore, the gross margin over that period was 62.3%.
GERN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Geron Corporation reported an operating income of 158.00K and revenue of 51.84M, resulting in an operating margin of 0.3%.
RMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, ResMed Inc. reported an operating income of 499.81M and revenue of 1.43B, resulting in an operating margin of 34.9%.
GERN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Geron Corporation reported a net income of -3.64M and revenue of 51.84M, resulting in a net margin of -7.0%.
RMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, ResMed Inc. reported a net income of 398.73M and revenue of 1.43B, resulting in a net margin of 27.9%.
Frequently Asked Questions
GERN and RMD have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GERN has higher volatility (16.52%) compared to RMD (12.95%). In terms of maximum drawdown, GERN dropped -98.73% vs RMD's -61.61%.
GERN currently has the higher Sharpe Ratio (0.20 vs -0.79), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GERN and RMD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer